Free Trial

Global Medical REIT (GMRE) Stock Price, News & Analysis

Global Medical REIT logo
$32.49 +0.26 (+0.81%)
Closing price 03:59 PM Eastern
Extended Trading
$32.54 +0.05 (+0.15%)
As of 04:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Global Medical REIT Stock (NYSE:GMRE)

Advanced

Key Stats

Today's Range
$32.04
$32.82
50-Day Range
$30.56
$38.70
52-Week Range
$30.09
$48.13
Volume
194,734 shs
Average Volume
143,115 shs
Market Capitalization
$434.59 million
P/E Ratio
92.83
Dividend Yield
9.23%
Price Target
$45.75
Consensus Rating
Moderate Buy

Company Overview

Global Medical REIT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

GMRE MarketRank™: 

Global Medical REIT scored higher than 99% of companies evaluated by MarketBeat, and ranked 33rd out of 945 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Global Medical REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Global Medical REIT has a consensus price target of $45.75, representing about 39.8% upside from its current price of $32.73.

  • Amount of Analyst Coverage

    Global Medical REIT has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Global Medical REIT's stock forecast and price target.
  • Earnings Growth

    Earnings for Global Medical REIT are expected to grow by 3.70% in the coming year, from $0.81 to $0.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Global Medical REIT is 93.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Global Medical REIT is 93.73, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 29.83.

  • Price to Book Value per Share Ratio

    Global Medical REIT has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Global Medical REIT's valuation and earnings.
  • Percentage of Shares Shorted

    4.34% of the outstanding shares of Global Medical REIT have been sold short.
  • Short Interest Ratio / Days to Cover

    Global Medical REIT has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Global Medical REIT has recently decreased by 79.18%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    Global Medical REIT is a leading dividend payer. It pays a dividend yield of 9.59%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Global Medical REIT does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Global Medical REIT is 857.14%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 357.14% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.

  • Read more about Global Medical REIT's dividend.
  • Percentage of Shares Shorted

    4.34% of the outstanding shares of Global Medical REIT have been sold short.
  • Short Interest Ratio / Days to Cover

    Global Medical REIT has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Global Medical REIT has recently decreased by 79.18%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Global Medical REIT has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Global Medical REIT this week, compared to 3 articles on an average week.
  • Search Interest

    19 people have searched for GMRE on MarketBeat in the last 30 days. This is an increase of 217% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Global Medical REIT to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Global Medical REIT insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,963.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 8.50% of the stock of Global Medical REIT is held by insiders.

  • Percentage Held by Institutions

    57.52% of the stock of Global Medical REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Global Medical REIT's insider trading history.
Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GMRE Stock News Headlines

Citizens Jmp Upgrades Global Medical REIT (NYSE:GMRE) to "Outperform"
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
JMP Securities Upgrades Global Medical REIT (GMRE)
See More Headlines

GMRE Stock Analysis - Frequently Asked Questions

Global Medical REIT's stock was trading at $38.60 at the beginning of 2025. Since then, GMRE stock has decreased by 15.2% and is now trading at $32.7260.

Global Medical REIT Inc. (NYSE:GMRE) issued its quarterly earnings data on Tuesday, August, 5th. The company reported $1.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.15. The company had revenue of $37.88 million for the quarter, compared to analysts' expectations of $35.57 million. Global Medical REIT had a trailing twelve-month return on equity of 2.21% and a net margin of 7.32%.
Read the conference call transcript
.

Global Medical REIT's stock reverse split on Monday, September 22nd 2025.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, September 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Global Medical REIT's board authorized a share repurchase program on Wednesday, August 13th 2025, which allows the company to repurchase $50,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 11.1% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its stock is undervalued.

Global Medical REIT (GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT's top institutional shareholders include CWM LLC (0.03%). Insiders that own company stock include Mark Okey Decker Jr and Matthew Cypher.
View institutional ownership trends
.

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Medical REIT investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), AUO (AUOTY), The RMR Group (RMR), Waste Connections (WCN), Voyager Therapeutics (VYGR) and Humana (HUM).

Company Calendar

Last Earnings
8/05/2025
Record date for 10/15 Dividend
9/29/2025
Ex-Dividend for 10/15 Dividend
9/29/2025
Dividend Payable
10/15/2025
Today
10/16/2025
Next Earnings (Confirmed)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
REIT - EQTY TRUST - OTHER
Sub-Industry
Trading
Current Symbol
NYSE:GMRE
CIK
1533615
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$58.75
Low Price Target
$40.00
Potential Upside/Downside
+40.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.35
Trailing P/E Ratio
93.27
Forward P/E Ratio
40.31
P/E Growth
N/A
Net Income
$6.63 million
Net Margins
7.32%
Pretax Margin
7.50%
Return on Equity
2.21%
Return on Assets
0.82%

Debt

Debt-to-Equity Ratio
1.56
Current Ratio
0.28
Quick Ratio
0.28

Sales & Book Value

Annual Sales
$141.60 million
Price / Sales
3.08
Cash Flow
$5.03 per share
Price / Cash Flow
6.49
Book Value
$36.00 per share
Price / Book
0.91

Miscellaneous

Outstanding Shares
13,376,000
Free Float
12,239,000
Market Cap
$436.73 million
Optionable
Optionable
Beta
1.19
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:GMRE) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners